Healthcare Transactions and Regulatory
- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Healthcare Transactions and Regulatory
Healthcare Transactions and Regulatory
The combination of our senior transactional counsel and our regulatory expertise makes us valued counsel in closing healthcare industry mergers, acquisitions, joint ventures, affiliations and other collaborations. Our practice is national in scope and involves all substantive aspects of healthcare transactions, including multistate regulatory approvals, legal risk assessments, tax structuring, antitrust analysis, and public company and going-private issues.
Lawyers
View all
Insights
Thought Leadership
September 2, 2022
Tamra Moore Appointed to Leadership Positions in ABA’s Science & Technology Law Section
Client Alert
October 4, 2021
Study Shows Hospital M&A Deals Linked to Improved Quality of Care
Client Alert
April 2, 2021
Florida Passes Law Limiting COVID-19 Lawsuits
News
In the News · Source: The Global Legal Post, Law.com International, The Lex 100, Legal Era and Australasian Lawyer
November 24, 2021
M&A partner Parveet Singh Gandoak joins the firm’s Corporate, Finance and Investments practice group in Singapore
Press Release
November 23, 2021
King & Spalding Recruits Parveet Singh Gandoak as M&A Partner in Singapore
In the News · Source: Bloomberg Law, Bloomberg Tax, Law360, ICLG News, The American Lawyer, New York Law Journal, The Deal, The National Law Journal and Thomson Reuters Westlaw Today
January 26, 2021
Healthcare partner Rick Zall joins the firm’s healthcare transactional and regulatory practice group in New York
Cases & Deals
November 16, 2021
DL Software group acquires Sephira
August 11, 2021
Sharecare Acquires Digital On-Demand Platform CareLinx
Close